SKU: F81≥ 99% HPLC
GDF-8 153
Research Compound · Research use only

GDF-8 153GDF-8 153 is a synthetic peptide fragment corresponding to a sequence region of growth differentiation factor 8 (GDF-8, also known as myostatin), a secreted protein of the transforming growth factor beta (TGF-beta) superfamily. It is supplied as a lyophilized powder for in vitro biochemical work, including cell-free receptor-binding experiments and SMAD-responsive reporter assays, and as an analytical reference standard for reversed-phase HPLC, LC-MS, and peptide mapping. For research and laboratory use only. Not a drug, dietary supplement, or medical device, and not for human or animal consumption.

4.1 on Trustpilot · 46 reviews
$134.99/ vial · 1mg
Out of stock
Ships within 7-14 business days
Select Size
Volume Discounts

Notify me when 1mg is back

Out of Stock
99%+ PurityHPLC · third-party
COA Includedevery lot
USA BasedMidwest Region
For Research Use Only. This product is intended for laboratory and scientific research purposes only. It is not a drug or dietary supplement and is not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease.

Product Details

GDF-8 153 is a synthetic peptide fragment corresponding to a sequence region of growth differentiation factor 8 (GDF-8, also known as myostatin), a secreted protein of the transforming growth factor beta (TGF-beta) superfamily. It is supplied as a lyophilized research chemical for in vitro biochemical investigation and as an analytical reference material.


The signaling chemistry of the parent protein defines how the fragment is studied. Full-length GDF-8 associates with the activin type II receptors ActRIIB and ActRIIA together with the type I receptors ALK4 and ALK5, a coupling that results in phosphorylation of SMAD2 and SMAD3 and formation of a heteromeric complex with SMAD4. Fragments derived from the GDF-8 sequence are therefore used in cell-free and cell-culture systems to probe these molecular interactions — for example in surface plasmon resonance and ELISA-format receptor-binding experiments, competitive displacement assays against the GDF-8 propeptide and follistatin, and SMAD-responsive luciferase reporter assays in cultured cell lines.


In analytical chemistry the material serves as a reference standard for reversed-phase HPLC purity determination, LC-MS and MALDI-TOF mass confirmation, amino acid analysis, circular dichroism secondary-structure measurement, and peptide mapping of larger TGF-beta superfamily constructs. It is also used as a positive control in immunoassay development and in antibody epitope-mapping workflows.


Standard handling practice for peptide reference materials of this type applies: store the lyophilized solid desiccated at -20 C or below and protected from light, allow the vial to reach room temperature before opening, reconstitute in sterile water or dilute acetic acid, and aliquot working solutions to limit repeated freeze-thaw cycles.


Disclaimer: GDF-8 153 is supplied strictly for research and laboratory use only. This product is not a drug, dietary supplement, or medical device. It is not intended for human or animal consumption, and not for therapeutic, diagnostic, or clinical application. It has not been evaluated by the FDA, and no statement here should be read as a claim to diagnose, treat, cure, or prevent any condition. All handling should be performed by qualified researchers in accordance with applicable laboratory safety protocols and institutional guidelines.

Frequently Asked Questions About GDF-8 153

Answers summarize published research and are provided for laboratory research purposes only.

GDF-8 153 is a synthetic peptide fragment corresponding to a sequence region of growth differentiation factor 8, better known as myostatin. Myostatin is a secreted protein of the TGF-beta superfamily. GDF-8 153 is supplied by Biotech Compounds as a lyophilized powder for in vitro biochemical work and as an analytical reference standard. It is not the full-length protein.
Research has shown that full-length myostatin binds the activin type II receptors ActRIIB and ActRIIA together with the type I receptors ALK4 and ALK5. That binding leads to phosphorylation of SMAD2 and SMAD3 and formation of a complex with SMAD4, which then regulates gene expression. GDF-8 153 gives researchers a defined fragment of the myostatin sequence for probing pieces of this interaction in vitro.
The primary research use of GDF-8 153 is in cell-free and cell-culture binding experiments. Researchers use the fragment in surface plasmon resonance and ELISA-format receptor-binding assays, in competitive displacement assays against the myostatin propeptide and Follistatin, and in SMAD-responsive luciferase reporter assays in cultured cell lines. These experiments map which regions of the myostatin sequence participate in receptor and binding-partner interactions.
GDF-8 153 serves as a reference material in analytical chemistry. Laboratories use it for reversed-phase HPLC purity determination, LC-MS and MALDI-TOF mass confirmation, amino acid analysis, circular dichroism secondary-structure measurement, and peptide mapping of larger TGF-beta superfamily constructs. GDF-8 153 is also used as a positive control in immunoassay development and in antibody epitope-mapping workflows.
GDF-8 153 is a research tool, not an investigational medicine. Its use is documented in in vitro biochemical studies, receptor-binding assays, and analytical method development. The myostatin pathway it belongs to has been studied in animal models and in clinical trials of other myostatin-targeting agents, but GDF-8 153 itself is supplied by Biotech Compounds solely for laboratory work such as binding assays and reference analysis.
GDF-8 153 and ACE-031 are both tied to the myostatin pathway but are very different molecules. GDF-8 153 is a synthetic fragment of the myostatin sequence used in vitro as a binding-assay reagent and reference standard. ACE-031 is a soluble ActRIIB decoy receptor fusion protein that research has reported binds myostatin and related ligands. Follistatin, another Biotech Compounds product, is a natural myostatin-binding glycoprotein.
Allow the GDF-8 153 vial to reach room temperature before opening so condensation does not form on the lyophilized solid. Reconstitute in sterile water or dilute acetic acid, such as the Acetic Acid 0.6% sold on the site, adding the liquid slowly against the inner wall. Swirl gently until dissolved and never shake. Divide the working solution into aliquots so that repeated freeze thaw cycles are avoided.
Store the lyophilized GDF-8 153 solid desiccated at -20 C or below and protected from light. After reconstitution, keep working aliquots refrigerated at 2 to 8 C for short-term use or frozen for longer holding, and avoid repeated freeze thaw cycles. As a peptide reference material, GDF-8 153 keeps its analytical value only when it is protected from moisture, light, and heat.
Yes. GDF-8 153 from Biotech Compounds is supplied at 99 percent or greater purity. Each lot is third-party tested for identity and purity, and the Certificate of Analysis is available on the product page. Because GDF-8 153 is often used as a reference standard, the lot data is especially useful for researchers who need a documented purity value.
GDF-8 153 has a molecular weight of approximately 7850 g/mol and the molecular formula C365H620N122O106S2. It is a synthetic peptide fragment, so it represents a defined region of the myostatin sequence rather than the complete mature protein. The two sulfur atoms in the formula reflect cysteine or methionine residues within that region.
No. GDF-8 153 is sold by Biotech Compounds strictly as a research material for laboratory research by qualified researchers and research organizations. Purchasers must be 21 or older. GDF-8 153 is not a drug, dietary supplement, or medical device, has not been evaluated by any regulatory agency, and is not for human or animal consumption.

Purity, documented